Sort
48,018 grants matching “immunotherapy”
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$572,168Dan R Littman · New York University School Of Medicine · R01 · FY2021 · CA
Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer
$572,168Dan R Littman · New York University School Of Medicine · R01 · FY2025 · CA
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy.
$572,160Mary L. Disis · University Of Washington · R01 · FY2010 · CA
The use of chitosan for cancer vaccine delivery
$572,121John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Myeloid-lineage cells and immunopathology in Leishmania braziliensis
$572,099Phillip A. Scott · University Of Pennsylvania · U01 · FY2014 · AI
Myeloid-lineage cells and immunopathology in Leishmania braziliensis
$572,098Phillip A. Scott · University Of Pennsylvania · U01 · FY2015 · AI
Identifying Therapeutic Targets for Stage III Melanoma
$571,965Anand K Ganesan · University Of California-Irvine · R01 · FY2022 · CA
Cooperation of the TAM and Abl family kinases in therapeutic resistance in HNC
$571,864Deric L Wheeler · University Of Wisconsin-Madison · R01 · FY2024 · CA
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
$571,835Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2025 · NS
Bioinformatic Tools for Interpretation of Glycan Array Data
$571,833Jian Zhang · Z Biotech, Llc · R43 · FY2019 · GM
Fgl2 neutralizing therapy for inducing tumor specific brain resident immune memory against CNS tumor relapse
$571,813Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · NS
Linking Synucleinopathy and Dysfunction of Olfactory Pathways
$571,807Patrik Brundin · Van Andel Research Institute · R01 · FY2017 · DC
Engineering immunotherapeutic probiotics to mitigate irAE
$571,668Tal Danino · Columbia Univ New York Morningside · U01 · FY2024 · CA
ANTIVIRAL &ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
$571,650Mount Sinai School Of Medicine Of Nyu · R01 · FY2004 · AA
3-D spatial approach to discover genomic effectors of immunosuppression during malignant transformation
$571,644Joseph F Costello · University Of California, San Francisco · R01 · FY2021 · CA
Testing the role of BATF as a pioneer transcription factor in effector T cells
$571,546William Nicholas Haining · Dana-Farber Cancer Inst · R01 · FY2016 · AI
Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NF-kB Activation and Response in Primary CNS Lymphoma
$571,523James Louis Rubenstein · University Of California, San Francisco · R01 · FY2023 · CA
Dissecting Molecular Mechanisms of Tumor-Induced Myeloid-Mediated Immune Suppression in Triple-Negative Breast Cancer
$571,496Jianmin Zhang · University Of Toledo Health Sci Campus · R01 · FY2024 · CA
Combating melanoma resistance by targeting ABL1/2
$571,489Rina Plattner · University Of Kentucky · R01 · FY2023 · CA
Mucosal T cell memory to pathogens
$571,485David Masopust · University Of Minnesota · R37 · FY2025 · AI
Mucosal T cell memory to pathogens
$571,485David Masopust · University Of Minnesota · R37 · FY2024 · AI
Single Cell Methods for Bioeffector Discovery and Analysis
$571,471Brian O Bachmann · Vanderbilt University · R01 · FY2022 · CA
Elucidating the Role of Cancer-Associated FGL1 in Tumor Immunity and Developing FGL1-Guided Anti-LAG-3 Cancer Immunotherapy
$571,456Jun Wang · New York University School Of Medicine · R37 · FY2025 · CA
Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for glioma
$571,444Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2023 · CA
Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for glioma
$571,444Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2025 · CA